Literature DB >> 24425039

Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA).

Badri N Vardarajan1, Kelley M Faber2, Thomas D Bird3, David A Bennett4, Roger Rosenberg5, Bradley F Boeve6, Neill R Graff-Radford7, Alison M Goate8, Martin Farlow9, Robert A Sweet10, Rafael Lantigua11, Martin Z Medrano12, Ruth Ottman13, Daniel J Schaid14, Tatiana M Foroud2, Richard Mayeux15.   

Abstract

IMPORTANCE: Late-onset Alzheimer disease (LOAD), defined as onset of symptoms after age 65 years, is the most common form of dementia. Few reports investigate incidence rates in large family-based studies in which the participants were selected for family history of LOAD.
OBJECTIVE: To determine the incidence rates of dementia and LOAD in unaffected members in the National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA) family studies. DESIGN, SETTING, AND PARTICIPANTS: Families with 2 or more affected siblings who had a clinical or pathological diagnosis of LOAD were recruited as a part of the NIA-LOAD/NCRAD Family Study. A cohort of Caribbean Hispanics with familial LOAD was recruited in a different study at the Taub Institute for Research on Alzheimer's Disease and the Aging Brain in New York and from clinics in the Dominican Republic as part of the EFIGA study. MAIN OUTCOMES AND MEASURES: Age-specific incidence rates of LOAD were estimated in the unaffected family members in the NIA-LOAD/NCRAD and EFIGA data sets. We restricted analyses to families with follow-up and complete phenotype information, including 396 NIA-LOAD/NCRAD and 242 EFIGA families. Among the 943 at-risk family members in the NIA-LOAD/NCRAD families, 126 (13.4%) developed dementia, of whom 109 (86.5%) met criteria for LOAD. Among 683 at-risk family members in the EFIGA families, 174 (25.5%) developed dementia during the study period, of whom 145 (83.3%) had LOAD.
RESULTS: The annual incidence rates of dementia and LOAD in the NIA-LOAD/NCRAD families per person-year were 0.03 and 0.03, respectively, in participants aged 65 to 74 years; 0.07 and 0.06, respectively, in those aged 75 to 84 years; and 0.08 and 0.07, respectively, in those 85 years or older. Incidence rates in the EFIGA families were slightly higher, at 0.03 and 0.02, 0.06 and 0.05, 0.10 and 0.08, and 0.10 and 0.07, respectively, in the same age groups. Contrasting these results with the population-based estimates, the incidence was increased by 3-fold for NIA-LOAD/NCRAD families (standardized incidence ratio, 3.44) and 2-fold among the EFIGA compared with the NIA-LOAD/NCRAD families (1.71). CONCLUSIONS AND RELEVANCE: The incidence rates for familial dementia and LOAD in the NIA-LOAD/NCRAD and EFIGA families are significantly higher than population-based estimates. The incidence rates in all groups increase with age. The higher incidence of LOAD can be explained by segregation of Alzheimer disease-related genes in these families or shared environmental risks.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24425039      PMCID: PMC4000602          DOI: 10.1001/jamaneurol.2013.5570

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  43 in total

1.  Colloquium paper: genome-wide patterns of population structure and admixture among Hispanic/Latino populations.

Authors:  Katarzyna Bryc; Christopher Velez; Tatiana Karafet; Andres Moreno-Estrada; Andy Reynolds; Adam Auton; Michael Hammer; Carlos D Bustamante; Harry Ostrer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-05       Impact factor: 11.205

2.  Low education and childhood rural residence: risk for Alzheimer's disease in African Americans.

Authors:  K S Hall; S Gao; F W Unverzagt; H C Hendrie
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

3.  Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project.

Authors:  L Letenneur; V Gilleron; D Commenges; C Helmer; J M Orgogozo; J F Dartigues
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

4.  Prevalence of moderate and severe Alzheimer dementia and multi-infarct dementia in the population of southeastern Sicily.

Authors:  E A Corso; G Campo; A Triglio; A Napoli; A Reggio; F Lanaia
Journal:  Ital J Neurol Sci       Date:  1992-04

5.  Prevalence of Alzheimer's disease and other dementing disorders in Pamplona, Spain.

Authors:  J M Manubens; J M Martínez-Lage; F Lacruz; J Muruzabal; R Larumbe; C Guarch; T Urrutia; P Sarrasqueta; P Martínez-Lage; W A Rocca
Journal:  Neuroepidemiology       Date:  1995       Impact factor: 3.282

6.  Prevalence estimation of dementia in a rural area of Korea.

Authors:  J I Woo; J H Lee; K Y Yoo; C Y Kim; Y I Kim; Y S Shin
Journal:  J Am Geriatr Soc       Date:  1998-08       Impact factor: 5.562

7.  Assessing cognitive abilities and dementia in a predominantly illiterate population of older individuals in Kinmen.

Authors:  H C Liu; P Chou; K N Lin; S J Wang; J L Fuh; H C Lin; C Y Liu; G S Wu; E B Larson; L R White
Journal:  Psychol Med       Date:  1994-08       Impact factor: 7.723

8.  Senile dementia of the Alzheimer type in the Lundby Study. I. A prospective, epidemiological study of incidence and risk during the 15 years 1957-1972.

Authors:  O Hagnell; A Franck; A Gräsbeck; R Ohman; L Ojesjö; L Otterbeck; B Rorsman
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

9.  Incidence and causes of nondegenerative nonvascular dementia: a population-based study.

Authors:  David S Knopman; Ronald C Petersen; Ruth H Cha; Steven D Edland; Walter A Rocca
Journal:  Arch Neurol       Date:  2006-02

10.  Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study.

Authors:  T Yoshitake; Y Kiyohara; I Kato; T Ohmura; H Iwamoto; K Nakayama; S Ohmori; K Nomiyama; H Kawano; K Ueda
Journal:  Neurology       Date:  1995-06       Impact factor: 9.910

View more
  24 in total

1.  Genetic variants associated with susceptibility to psychosis in late-onset Alzheimer's disease families.

Authors:  Sandra Barral; Badri N Vardarajan; Dolly Reyes-Dumeyer; Kelley M Faber; Thomas D Bird; Debby Tsuang; David A Bennett; Roger Rosenberg; Bradley F Boeve; Neill R Graff-Radford; Alison M Goate; Martin Farlow; Rafael Lantigua; Martin Z Medrano; Xinbing Wang; M Ilyas Kamboh; Mahmud Muhiedine Barmada; Daniel J Schaid; Tatiana M Foroud; Elise A Weamer; Ruth Ottman; Robert A Sweet; Richard Mayeux
Journal:  Neurobiol Aging       Date:  2015-08-15       Impact factor: 4.673

2.  Cerebrovascular Disease and Neurodegeneration in Alzheimer's Disease with and without a Strong Family History: A Pilot Magnetic Resonance Imaging Study in Dominican Republic.

Authors:  Angel Piriz; Dolly Reyes; Atul Narkhede; Vanessa A Guzman; Fawad Viqar; Irene B Meier; Mariana Budge; Pedro Mena; Stephen Dashnaw; Joseph Lee; Christiane Reitz; Jose Gutierrez; Luis Campos; Martin Medrano; Rafael Lantigua; Richard Mayeux; Adam M Brickman
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 3.  Alzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics.

Authors:  Richard A Hickman; Arline Faustin; Thomas Wisniewski
Journal:  Neurol Clin       Date:  2016-08-04       Impact factor: 3.806

4.  Progranulin mutations in clinical and neuropathological Alzheimer's disease.

Authors:  Badri N Vardarajan; Dolly Reyes-Dumeyer; Angel L Piriz; Rafael A Lantigua; Martin Medrano; Diones Rivera; Ivonne Z Jiménez-Velázquez; Eden Martin; Margaret A Pericak-Vance; William Bush; Lindsay Farrer; Jonathan L Haines; Li-San Wang; Yuk Yee Leung; Gerard Schellenberg; Walter Kukull; Philip De Jager; David A Bennett; Julie A Schneider; Richard Mayeux
Journal:  Alzheimers Dement       Date:  2022-02-09       Impact factor: 16.655

Review 5.  Alzheimer's and ABC transporters--new opportunities for diagnostics and treatment.

Authors:  Jens Pahnke; Oliver Langer; Markus Krohn
Journal:  Neurobiol Dis       Date:  2014-04-16       Impact factor: 5.996

6.  ABCD: Alzheimer's disease Biomarkers Comprehensive Database.

Authors:  Ashwani Kumar; Ankush Bansal; Tiratha Raj Singh
Journal:  3 Biotech       Date:  2019-09-03       Impact factor: 2.406

7.  A Genome-Wide Study of Single-Nucleotide Polymorphisms in MicroRNAs and Further In Silico Analysis Reveals Their Putative Role in Susceptibility to Late-Onset Alzheimer's Disease.

Authors:  Soraya Herrera-Espejo; Borja Santos-Zorrozua; Paula Alvarez-Gonzalez; Idoia Martin-Guerrero; Marian M de Pancorbo; Africa Garcia-Orad; Elixabet Lopez-Lopez
Journal:  Mol Neurobiol       Date:  2020-09-06       Impact factor: 5.590

8.  Gene-Environment-Time Interactions in Neurodegenerative Diseases: Hypotheses and Research Approaches.

Authors:  Walter G Bradley; Angeline S Andrew; Bryan J Traynor; Adriano Chiò; Tanya H Butt; Elijah W Stommel
Journal:  Ann Neurosci       Date:  2018-12-04

9.  The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease.

Authors:  Giuseppe Tosto; Thomas D Bird; David A Bennett; Bradley F Boeve; Adam M Brickman; Carlos Cruchaga; Kelley Faber; Tatiana M Foroud; Martin Farlow; Alison M Goate; Neill R Graff-Radford; Rafael Lantigua; Jennifer Manly; Ruth Ottman; Roger Rosenberg; Daniel J Schaid; Nicole Schupf; Yaakov Stern; Robert A Sweet; Richard Mayeux
Journal:  JAMA Neurol       Date:  2016-10-01       Impact factor: 18.302

Review 10.  Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers.

Authors:  Guochao Zhong; Yi Wang; Yong Zhang; Jeff Jianfei Guo; Yong Zhao
Journal:  PLoS One       Date:  2015-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.